We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Product Safety Report for Esapharma Movate Steroid Cream presenting a serious chemical risk.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Advice and guidance on the health needs of migrant patients from Ecuador for healthcare practitioners.
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
Our approach to working with clients and making applications.
Guidance and support on coronavirus (COVID-19) in Scotland.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Imposing safeguard measures for imports of certain steel products.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
medac GmbH (t/a medac Pharma LLP) is recalling further batches due to particles detected during long-term stability tests.
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
Information for patients who have been prescribed Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets COVID-19 antiviral medication.
Volume 20 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
The characteristics, diagnosis, management, surveillance and epidemiology of Shiga toxin-producing Escherichia coli (STEC).
Guidance on sexual transmission of Zika virus and methods of prevention.
Product Safety Report for SIVOP Parfums & Cosmétiques Clair-Liss Lightening Body Cream presenting a serious chemical risk.
Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.
Information on COVID-19, including guidance on the assessment and management of suspected UK cases.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.